The effect of wait times on oncological outcomes from periampullary adenocarcinomas

Journal of Surgical Oncology

Volumn 107, Issue 8, 2013, Pages 853-858

  McLean, Spencer R ^a   Karsanji, Divya ^a   Wilson, Jennifer ^a   Dixon, Elijah ^a   Sutherland, Francis R ^a   Pasieka, Janice ^a   Ball, Chad ^a   Bathe, Oliver F ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

pancreatic cancer; periampullary cancers; resection rate; survival; wait times

Indexed keywords

ARTICLE; CANCER SURGERY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PERIAMPULLARY ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AMPULLA OF VATER; CANADA; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84878329787     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23338     Document Type: Article

References (20)

1. Garcea G, Dennison AR, Pattenden CJ, et al.: Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008; 9: 99-132. Epub 2008/03/11. (Pubitemid 351611725)
2. Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007; 297: 267-277. Epub 2007/01/18. (Pubitemid 46143304)
3. Neoptolemos JP, Stocken DD, Friess H, et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210. Epub 2004/03/19. (Pubitemid 38339364)
4. Hidalgo M:, Pancreatic cancer. N Engl Med J 2010; 362: 1605-1617. Epub 2010/04/30.
5. Parsons CM, Sutcliffe JL, Bold RJ:, Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 2008; 15: 429-435. Epub 2008/08/02.
6. Christensen ED, Harvald T, Jendresen M, et al.: The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 1997; 12: 880-884. Epub 1998/03/07. (Pubitemid 28088224)
7. Croome KP, Chudzinski R, Hanto DW:, Increasing time delay from presentation until surgical referral for hepatobiliary malignancies. HPB (Oxford) 2010; 12: 644-648. Epub 2010/10/22.
8. Kulkarni GS, Urbach DR, Austin PC, et al.: Longer wait times increase overal mortality in patients with bladder cancer. J Urol 2009; 182: 1318-1324.
9. Langenbach MR, Schmidt J, Neumann J, et al.: Delay in treatment of colorectal cancer: Multifactorial problem. World J Surg 2003; 27: 304-308. (Pubitemid 36920142)
10. Sainsbury R, Johnston C, Haward B:, Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lancet 1999; 353: 1132-1135. Epub 1999/04/21. (Pubitemid 29155205)
11. Statistics Canada Access to health care services in Canada: January to December 2005. 2006 [cited 2010 November 17]; Available from: http://www.statcan.gc.ca/pub/82-575-x/82-575-x2006002-eng.htm.
12. Raptis DA, Fessas C, Belasyse-Smith P, et al.: Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon 2010; 8: 239-246. Epub 2010/08/17.
13. Bakkevold KE, Arnesjo B, Kambestad B:, Carcinoma of the pancreas and papilla of Vater-assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients. Eur J Surg Oncol 1992; 18: 494-507. Epub 1992/10/01.
14. Karmazanovsky G, Fedorov V, Kubyshkin V, et al.: Pancreatic head cancer: Accuracy of CT in determination of resectability. Abdom Imaging 2005; 30: 488-500. Epub 2005/03/11. (Pubitemid 41176128)
15. van der Gaag NA, Rauws EA, van Eijck CH, et al.: Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362: 129-137. Epub 2010/01/15.
16. Sohn TA, Yeo CJ, Cameron JL, et al.: Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579. Epub 2001/04/18.
17. Paterson WG, Depew WT, Paré P, et al.: Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol 2006; 20: 411-423. (Pubitemid 44083430)
18. Department of Health The NHS Cancer plan: a plan for investment, a plan for reform. 2000 [cited 2010 November 17]; Available from: http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH-4009609.
19. Conroy T, Desseigne F, Ychou M, et al.: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825. Epub 2011/05/13.
20. Eshuis WJ, van der Gaag NA, Rauws EA, et al.: Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg 2010; 252: 840-849. Epub 2010/11/03.